Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Shinpoong Pharmaceutical (019170 KS)
Watchlist
79
Analysis
Health Care
•
South Korea
Shin Poong Pharmaceutical Co., Ltd. manufactures pharmaceutical raw materials and prescription drugs, such as cephalosporin antibiotics, hemostatics, sedative agents, and anti-diabetics.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Shinpoong Pharmaceutical
•
07 Jan 2022 00:54
Shinpoong Pharmaceutical (019170 KS): Three Concerns Are Clouding the Upside Potential
Concerns regarding the slush fund is the major overhang on the stock price. Oral COVID-19 drug development cannot be considered a major catalyst...
Tina Banerjee
Follow
488 Views
Share
bearish
•
BNC Korea
•
29 Oct 2021 22:50
BNC Korea (256840 KS): Oral COVID-19 Treatment No More Remains a Catalyst
In-licensed oral COVID-19 treatment no longer remains a catalyst after competitor's encouraging clinical trial results. Other oral treatments are...
Tina Banerjee
Follow
258 Views
Share
bearish
•
LG Display
•
30 Sep 2021 19:22
Local Institutions Drive Higher Shorts in KOSPI
In this insight, we discuss the top 10 most heavily shorted stocks in KOSPI (amount shorted/market cap).These heavily shorted stocks have...
Douglas Kim
Follow
468 Views
Share
bearish
•
Quantitative Analysis
•
11 Sep 2021 05:48
Asia Shorts: Meituan, CMB, Li Ning, Sekisui, Toyo Seikan, Toshiba, Kakao, HMM, LGE, Wan Hai, TSMC
The Insight looks at movements in short interest across HK, Japan, Korea and Taiwan stocks and highlights large increases/decreases in shorts to...
Brian Freitas
Follow
353 Views
Share
bullish
•
Krafton
•
31 Aug 2021 17:21
KRX BBIG Index Rebalance: Krafton, SK Bioscience, SK IE Tech Included (Among Others)
Krafton has been added to the Game index, SK IE Tech added to the Battery index, SK Bioscience to the Bio index. Lots of flow on some names....
Brian Freitas
Follow
382 Views
Share
First
Previous
3
4
5
6
7
8
9
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x